| Oral potentially malignant disorders: etiology, pathogenesis, and transformation into oral cancer P Kumari, P Debta, A Dixit Frontiers in pharmacology 13, 825266, 2022 | 81 | 2022 |
| Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity S Kumar, B Singh, P Kumari, PV Kumar, G Agnihotri, S Khan, TK Beuria, ... Computational and Structural Biotechnology Journal 19, 1998-2017, 2021 | 41 | 2021 |
| Designing of multi-epitope chimeric vaccine using immunoinformatic platform by targeting oncogenic strain HPV 16 and 18 against cervical cancer PK Anoop Kumar, Utkarsha Sahu, Pratima Kumari, Anshuman Dixit scientific report, 2022 | 17 | 2022 |
| Identification of therapeutically potential targets and their ligands for the treatment of OSCC P Kumari, S Kumar, M Sethy, S Bhue, BK Mohanta, A Dixit Frontiers in Oncology 12, 910494, 2022 | 6 | 2022 |
| GeMemiOM-the first curated database on Genes, putative Methylation study targets, and microRNA targets for Otitis Media. K Abhishek, BK Mohanta, P Kumari, A Dixit, VR Puppala Journal of Genetics and Genomics= Yi Chuan xue bao, S1673-8527 (23) 00162, 2023 | | 2023 |
| Stagewise identification of significantly mutated and dysregulated gene clusters in major molecular classes of breast invasive carcinoma S Agarwal, S Naik, P Kumari, SK Mishra, AK Adhya, SK Kashaw, A Dixit bioRxiv, 2020.05. 30.125260, 2020 | | 2020 |
Anshuman DixitSenior Scientist, Institute of Life Sciences, Bhubaneswar, India在 ils.res.in 的电子邮件经过验证
